Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,140.00
-25.00 (-0.60%)
Last updated: Nov 25, 2025, 2:49 PM KST

Yuyu Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
66,20572,90385,445102,750130,082108,199
Upgrade
Market Cap Growth
-7.23%-14.68%-16.84%-21.01%20.23%62.16%
Upgrade
Enterprise Value
80,05676,861119,950114,352120,293117,748
Upgrade
Last Close Price
4200.004505.005162.016081.017509.626924.50
Upgrade
PE Ratio
14.589.62---108.35
Upgrade
PS Ratio
0.470.550.620.741.131.10
Upgrade
PB Ratio
0.480.540.710.831.010.92
Upgrade
P/TBV Ratio
0.540.610.810.931.110.99
Upgrade
P/FCF Ratio
25.734.09----
Upgrade
P/OCF Ratio
7.372.92203.03-28.85-
Upgrade
EV/Sales Ratio
0.570.580.870.821.041.20
Upgrade
EV/EBITDA Ratio
4.764.2124.6925.7821.0911.58
Upgrade
EV/EBIT Ratio
7.156.11--100.2318.78
Upgrade
EV/FCF Ratio
31.124.31----
Upgrade
Debt / Equity Ratio
0.210.250.330.320.300.17
Upgrade
Debt / EBITDA Ratio
1.751.848.118.866.871.96
Upgrade
Debt / FCF Ratio
11.251.89----
Upgrade
Asset Turnover
0.690.660.700.720.670.67
Upgrade
Inventory Turnover
2.001.982.112.642.892.60
Upgrade
Quick Ratio
0.920.971.140.862.432.20
Upgrade
Current Ratio
1.771.582.031.503.303.50
Upgrade
Return on Equity (ROE)
5.40%8.06%-4.55%-3.51%-0.75%2.32%
Upgrade
Return on Assets (ROA)
3.37%3.88%-0.24%-0.19%0.43%2.68%
Upgrade
Return on Capital (ROIC)
4.06%4.79%-0.29%-0.22%0.49%3.08%
Upgrade
Return on Capital Employed (ROCE)
7.40%8.80%-0.50%-0.50%0.70%4.60%
Upgrade
Earnings Yield
7.38%11.96%-8.40%-5.83%-1.70%1.19%
Upgrade
FCF Yield
3.89%24.47%-4.79%-11.20%-1.20%-13.60%
Upgrade
Dividend Yield
2.40%2.22%----
Upgrade
Payout Ratio
31.97%----118.38%
Upgrade
Buyback Yield / Dilution
-9.19%-3.29%1.89%-3.90%-32.81%19.87%
Upgrade
Total Shareholder Return
-6.79%-1.07%1.89%-3.90%-32.81%19.87%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.